RecruitingPhase 1NCT02811510

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I

Sponsor

Yale University

Enrollment

40 participants

Start Date

Jun 1, 2016

Study Type

INTERVENTIONAL

Conditions

Cannabis

Summary

The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.

Eligibility

Min Age: 18 YearsMax Age: 55 Years

Inclusion Criteria2

At least one lifetime exposure to cannabis
Good physical and mental health

Exclusion Criteria4

Cannabis naive individuals
Major current or recent stressors
Taking estrogen supplements or oral contraceptive pills (for women)
Sesame oil allergy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPlacebo

Placebo pill (no active cannabinoids)

DRUGDronabinol

10 mg capsule of Dronabinol will be administered orally.

Locations(1)

Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine

West Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02811510

Related Trials

Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury

NCT048108581 location